Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Yadith Karina López-García"'
1
Are Delays in the Diagnosis and Treatment of Acute Leukemia in a Middle-Income Country Associated with Poor Outcomes?
Autor: Mayra Valdez-Carrizales, Juan Rangel-Patiño, Jorge Adrian Nuñez-Zuno, Yadith Karina López García, Elia Ixel Apodaca, Roberta Demichelis
Publikováno v: Blood. 138:5008-5008
Introduction: Mexico, like other Middle-Income Countries (MIC), faces many challenges in the care of patients with cancer. The number of practicing physicians is lower than the recommended for the OECD, there is It has been reported that children wit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1e9ef3390b578e4112b7c1e1070b9058
https://doi.org/10.1182/blood-2021-148056
Zobrazit plný text záznamu
3
Clinical presentation in thrombotic thrombocytopenic purpura: Real-world data from two Mexican institutions
Autor: Yadith Karina López-García, Emmanuel Bugarin-Estrada, Guillermo J. Ruiz-Argüelles, Erik Alejandro Díaz-Chuc, David Gómez-Almaguer, José Manuel Priesca-Marin, José Carlos Jaime-Pérez, Andrés Gómez-De León
Publikováno v: Journal of clinical apheresis. 33(6)
Background Thrombotic thrombocytopenic purpura (TTP) is a hematologic disease that can be fatal if not treated early. We aimed to describe the clinical characteristics of Mexican patients with idiopathic TTP. Study design and methods We conducted a r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1f2f81af3d6ccb85b773abcf9aa1159
https://pubmed.ncbi.nlm.nih.gov/30321453
Zobrazit plný text záznamu
4
Iron deficiency anemia referral to the hematologist. Real-world data from Mexico: the need for targeted teaching in primary care
Autor: Mariana Itzel López Garza, David Gómez-Almaguer, José Carlos Jaime-Pérez, Yadith Karina López-García, Perla R. Colunga-Pedraza, Luz Tarín-Arzaga
Publikováno v: Hematology (Amsterdam, Netherlands). 23(9)
To determine the referral patterns and etiology of iron deficiency anemia (IDA) at an academic hematology center in northeast Mexico.We included all consecutive outpatients older than 16 years, non-pregnant, with IDA diagnosed in the Hematology Servi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2bf16c1bff2c84e0eb1a1da9468b574
https://pubmed.ncbi.nlm.nih.gov/29637844
Zobrazit plný text záznamu
5
Danazol as First-Line Therapy for Myelodysplastic Syndrome
Autor: Olga G. Cantú-Rodríguez, María Alejandra Garza-Ledezma, José Carlos Jaime-Pérez, César Homero Gutiérrez-Aguirre, Yadith Karina López-García, David Gómez-Almaguer, Julia E. Colunga-Pedraza, Perla R. Colunga-Pedraza, Andrés Gómez-De León, Rosa Elena Lozano-Morales, Guillermo Sotomayor-Duque, Erick Joel Rendón-Ramírez
Publikováno v: Clinical lymphoma, myelomaleukemia. 18(2)
Allogeneic stem cell transplantation (ASCT) represents the only option with a potential cure rate of 30% to 50% in myelodysplastic syndrome (MDS); however, 5% of patients are optimal candidates for this management. Therapeutic options are limited in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::651d29b6b3cdcfae3e9b14fbe0fce1c8
https://pubmed.ncbi.nlm.nih.gov/29268959
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje